Inflammasomes in Common Immune-Related Skin Diseases

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2020 Jun 13

PMID 32528469

Citations 38

Authors

Lili Tang

Fusheng Zhou

Affiliations

Soon will be listed here.

Abstract

The inflammasome is an important protein complex that cleaves the proinflammatory cytokines pro-IL-1β and pro-IL-18 into their active forms. Owing to its critical role in eliciting innate immune responses, IL-1β has been suggested to contribute to various skin diseases, including psoriasis, vitiligo, systemic lupus erythematosus (SLE), and atopic dermatitis (AD). Recently, several types of activators and inhibitors of different inflammasomes, as well as inflammasome-related genes and genetic susceptibility loci, have been identified in these immune-related common skin diseases. In particular, inflammasome activators and inhibitors presented highly cell-type-specific activity, suggesting that the inflammasome might perform different functions in different cell types. Moreover, most of these findings were based on experimental disease models, and the clinical features of the models partly resemble the typical symptoms of the diseases. In this review, from the perspective of activators and inhibitors, we collected evidence from the widely-studied inflammasomes, NLRP3, AIM2, and NLRP1, in psoriasis, vitiligo, SLE, and AD. Importantly, some small-molecule inhibitors hold therapeutic promise for the treatment of these diseases.

Citing Articles

Enhancing Transcutaneous Drug Delivery: Advanced Perspectives on Skin Models.

Ribeiro A, Pereira-Leite C, Rosado C, Aruci E, Colley H, Kortekaas Krohn I JID Innov. 2025; 5(2):100340.

PMID: 39925780 PMC: 11803873. DOI: 10.1016/j.xjidi.2024.100340.

NLRP3 deficiency aggravated DNFB-induced chronic itch by enhancing type 2 immunity IL-4/TSLP-TRPA1 axis in mice.

Huang S, Chen Z, Peng Z, Wang Y, Yang F, Tang Y Front Immunol. 2025; 15:1450887.

PMID: 39867900 PMC: 11758165. DOI: 10.3389/fimmu.2024.1450887.

Life stage impact on the human skin ecosystem: lipids and the microbial community.

Pagac M, Davient B, Plado L, Lam H, Lee S, Ravikrishnan A NPJ Biofilms Microbiomes. 2025; 11(1):13.

PMID: 39800795 PMC: 11725588. DOI: 10.1038/s41522-025-00652-7.

Poly-D,L-Lactic Acid Filler Attenuates Ultraviolet B-Induced Skin Pigmentation by Reducing Destruction of the Basement Membrane.

Byun K, Seo S, Oh S, Jang J, Son K, Byun K Int J Mol Sci. 2024; 25(21).

PMID: 39519119 PMC: 11546917. DOI: 10.3390/ijms252111568.

Sprayable inflammasome-inhibiting lipid nanorods in a polymeric scaffold for psoriasis therapy.

Surve D, Fish A, Debnath M, Pinjari A, Lorenzana A, Piya S Nat Commun. 2024; 15(1):9035.

PMID: 39426974 PMC: 11490495. DOI: 10.1038/s41467-024-53396-x.

References

Pontillo A, Girardelli M, Kamada A, Pancotto J, Donadi E, Crovella S . Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity. 2012; 45(4):271-8. DOI: 10.3109/08916934.2011.637532. View

Hasegawa T, Nakashima M, Suzuki Y . Nuclear DNA damage-triggered NLRP3 inflammasome activation promotes UVB-induced inflammatory responses in human keratinocytes. Biochem Biophys Res Commun. 2016; 477(3):329-35. DOI: 10.1016/j.bbrc.2016.06.106. View

Rathinam V, Chan F . Inflammasome, Inflammation, and Tissue Homeostasis. Trends Mol Med. 2018; 24(3):304-318. PMC: 6456255. DOI: 10.1016/j.molmed.2018.01.004. View

Skendros P, Papagoras C, Lefaki I, Giatromanolaki A, Kotsianidis I, Speletas M . Successful response in a case of severe pustular psoriasis after interleukin-1β inhibition. Br J Dermatol. 2016; 176(1):212-215. DOI: 10.1111/bjd.14685. View

Carlstrom M, Ekman A, Petersson S, Soderkvist P, Enerback C . Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility. Exp Dermatol. 2012; 21(12):932-7. DOI: 10.1111/exd.12049. View

Coeshott C, Ohnemus C, Pilyavskaya A, Ross S, Wieczorek M, Kroona H . Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci U S A. 1999; 96(11):6261-6. PMC: 26869. DOI: 10.1073/pnas.96.11.6261. View

Panchanathan R, Duan X, Arumugam M, Shen H, Liu H, Choubey D . Cell type and gender-dependent differential regulation of the p202 and Aim2 proteins: implications for the regulation of innate immune responses in SLE. Mol Immunol. 2011; 49(1-2):273-80. PMC: 3211081. DOI: 10.1016/j.molimm.2011.08.022. View

Douglas T, Champagne C, Morizot A, Lapointe J, Saleh M . The Inflammatory Caspases-1 and -11 Mediate the Pathogenesis of Dermatitis in Sharpin-Deficient Mice. J Immunol. 2015; 195(5):2365-73. DOI: 10.4049/jimmunol.1500542. View

Man S, Karki R, Sasai M, Place D, Kesavardhana S, Temirov J . IRGB10 Liberates Bacterial Ligands for Sensing by the AIM2 and Caspase-11-NLRP3 Inflammasomes. Cell. 2016; 167(2):382-396.e17. PMC: 5074697. DOI: 10.1016/j.cell.2016.09.012. View

10.

Dai X, Sayama K, Tohyama M, Shirakata Y, Hanakawa Y, Tokumaru S . Mite allergen is a danger signal for the skin via activation of inflammasome in keratinocytes. J Allergy Clin Immunol. 2011; 127(3):806-14.e1-4. DOI: 10.1016/j.jaci.2010.12.006. View

11.

Hornung V, Bauernfeind F, Halle A, Samstad E, Kono H, Rock K . Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008; 9(8):847-56. PMC: 2834784. DOI: 10.1038/ni.1631. View

12.

Choubey D, Panchanathan R . Absent in Melanoma 2 proteins in SLE. Clin Immunol. 2017; 176:42-48. PMC: 5346332. DOI: 10.1016/j.clim.2016.12.011. View

13.

Satoh M, Reeves W . Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med. 1994; 180(6):2341-6. PMC: 2191761. DOI: 10.1084/jem.180.6.2341. View

14.

Shin M, Kang Y, Lee N, Kim S, Kang K, Lazova R . U1-small nuclear ribonucleoprotein activates the NLRP3 inflammasome in human monocytes. J Immunol. 2012; 188(10):4769-75. PMC: 3347773. DOI: 10.4049/jimmunol.1103355. View

15.

Pasparakis M, Haase I, Nestle F . Mechanisms regulating skin immunity and inflammation. Nat Rev Immunol. 2014; 14(5):289-301. DOI: 10.1038/nri3646. View

16.

Zuo X, Sun L, Yin X, Gao J, Sheng Y, Xu J . Whole-exome SNP array identifies 15 new susceptibility loci for psoriasis. Nat Commun. 2015; 6:6793. PMC: 4403312. DOI: 10.1038/ncomms7793. View

17.

Aira L, Goncalves D, Bossowski J, Rubio-Patino C, Chiche J, Paul-Bellon R . Caspase 1/11 Deficiency or Pharmacological Inhibition Mitigates Psoriasis-Like Phenotype in Mice. J Invest Dermatol. 2018; 139(6):1306-1317. DOI: 10.1016/j.jid.2018.11.031. View

18.

He J, Sun M, Tian S . Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation. Innate Immun. 2018; 24(5):307-315. PMC: 6830913. DOI: 10.1177/1753425918780985. View

19.

Huang L, Kuo H, Pan C, Lin Y, Huang Y, Li S . Multiomics analyses identified epigenetic modulation of the S100A gene family in Kawasaki disease and their significant involvement in neutrophil transendothelial migration. Clin Epigenetics. 2018; 10(1):135. PMC: 6211403. DOI: 10.1186/s13148-018-0557-1. View

20.

Shin M, Kang Y, Lee N, Wahl E, Kim S, Kang K . Self double-stranded (ds)DNA induces IL-1β production from human monocytes by activating NLRP3 inflammasome in the presence of anti-dsDNA antibodies. J Immunol. 2013; 190(4):1407-15. PMC: 3563755. DOI: 10.4049/jimmunol.1201195. View